Manufacture of remdesivir rises three-fold

COVID-19 State

Bengaluru: Amid the increasing demand for remdesivir, the Centre on Tuesday said the production of the antiviral drug has achieved three times the production capacity.

Union minister for state chemical and fertiliser, Mansukh Mandaviya said India’s remdesivir manufacturing capacity, earlier 38.8 lakh vials per month, has now been increased to 1.16 crore vials per month.

Remdesivir is an anti-malaria injection used to treat symptomatic Covid-19 patients.

The Drug Controller General of India approved the emergency use of remdesivir on June 1, 2020. Thereafter, it has been used widely in the country. Multiple scams, thefts and long queues outside hospitals, and pharmacies have been seen in the name of remdesivir. 

India is registering more than 3,000 deaths every day. On May 1, India’s daily Covid-19 cases created a global record of four lakh.

The vaccination campaign for those aged 18 and up has started on a bleak owing to a vaccine shortage in the country. Ramping up remdesivir production could come as a ray of hope to Covid-19 patients, experts say.


Leave a Reply

Your email address will not be published. Required fields are marked *